annual EBITDA:
$158.83M-$4.32M(-2.65%)Summary
- As of today (August 16, 2025), GDRX annual EBITDA is $158.83 million, with the most recent change of -$4.32 million (-2.65%) on December 31, 2024.
- During the last 3 years, GDRX annual EBITDA has risen by +$93.48 million (+143.06%).
- GDRX annual EBITDA is now -2.65% below its all-time high of $163.15 million, reached on December 31, 2023.
Performance
GDRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$50.03M+$1.81M(+3.76%)Summary
- As of today (August 16, 2025), GDRX quarterly EBITDA is $50.03 million, with the most recent change of +$1.81 million (+3.76%) on June 30, 2025.
- Over the past year, GDRX quarterly EBITDA has increased by +$6.86 million (+15.88%).
- GDRX quarterly EBITDA is now at all-time high.
Performance
GDRX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$178.12M+$6.86M(+4.00%)Summary
- As of today (August 16, 2025), GDRX TTM EBITDA is $178.12 million, with the most recent change of +$6.86 million (+4.00%) on June 30, 2025.
- Over the past year, GDRX TTM EBITDA has increased by +$69.13 million (+63.43%).
- GDRX TTM EBITDA is now at all-time high.
Performance
GDRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GDRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.6% | +15.9% | +63.4% |
| 3 y3 years | +143.1% | +394.0% | +120.2% |
| 5 y5 years | +0.8% | +8.0% | +5.8% |
GDRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2.6% | +143.1% | at high | +4277.5% | at high | +174.5% |
| 5 y | 5-year | -2.6% | +165.0% | at high | +117.0% | at high | +151.9% |
| alltime | all time | -2.6% | +165.0% | at high | +117.0% | at high | +151.9% |
GDRX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $50.03M(+3.8%) | $178.12M(+4.0%) |
| Mar 2025 | - | $48.22M(+15.2%) | $171.27M(+11.3%) |
| Dec 2024 | $158.83M(-2.6%) | $41.86M(+10.2%) | $153.92M(+5.5%) |
| Sep 2024 | - | $38.00M(-12.0%) | $145.85M(+33.8%) |
| Jun 2024 | - | $43.18M(+39.8%) | $108.99M(+0.9%) |
| Mar 2024 | - | $30.88M(-8.6%) | $108.03M(-0.7%) |
| Dec 2023 | $163.15M(+72.3%) | $33.79M(+2856.6%) | $108.82M(+11.3%) |
| Sep 2023 | - | $1.14M(-97.3%) | $97.75M(-0.0%) |
| Jun 2023 | - | $42.22M(+33.3%) | $97.76M(+48.9%) |
| Mar 2023 | - | $31.67M(+39.4%) | $65.67M(+0.7%) |
| Dec 2022 | $94.69M | $22.71M(+1859.9%) | $65.19M(+0.5%) |
| Sep 2022 | - | $1.16M(-88.6%) | $64.89M(-19.8%) |
| Jun 2022 | - | $10.13M(-67.5%) | $80.91M(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $31.19M(+39.1%) | $78.81M(+64.2%) |
| Dec 2021 | $65.34M(-126.7%) | $22.42M(+30.6%) | $48.00M(-117.8%) |
| Sep 2021 | - | $17.17M(+113.8%) | -$269.43M(-21.5%) |
| Jun 2021 | - | $8.03M(+2019.0%) | -$343.11M(+12.6%) |
| Mar 2021 | - | $379.00K(-100.1%) | -$304.82M(+18.6%) |
| Dec 2020 | -$244.48M(-255.2%) | -$295.01M(+422.1%) | -$257.11M(-466.4%) |
| Sep 2020 | - | -$56.50M(-222.0%) | $70.18M(-58.3%) |
| Jun 2020 | - | $46.31M(-3.7%) | $168.41M(+37.9%) |
| Mar 2020 | - | $48.09M(+49.0%) | $122.10M(+65.0%) |
| Dec 2019 | $157.57M(+81.0%) | $32.27M(-22.7%) | $74.00M(+77.3%) |
| Sep 2019 | - | $41.73M | $41.73M |
| Dec 2018 | $87.07M(+46.6%) | - | - |
| Dec 2017 | $59.41M(+112.1%) | - | - |
| Dec 2016 | $28.01M | - | - |
FAQ
- What is GoodRx Holdings, Inc. annual EBITDA?
- What is the all time high annual EBITDA for GoodRx Holdings, Inc.?
- What is GoodRx Holdings, Inc. annual EBITDA year-on-year change?
- What is GoodRx Holdings, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for GoodRx Holdings, Inc.?
- What is GoodRx Holdings, Inc. quarterly EBITDA year-on-year change?
- What is GoodRx Holdings, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for GoodRx Holdings, Inc.?
- What is GoodRx Holdings, Inc. TTM EBITDA year-on-year change?
What is GoodRx Holdings, Inc. annual EBITDA?
The current annual EBITDA of GDRX is $158.83M
What is the all time high annual EBITDA for GoodRx Holdings, Inc.?
GoodRx Holdings, Inc. all-time high annual EBITDA is $163.15M
What is GoodRx Holdings, Inc. annual EBITDA year-on-year change?
Over the past year, GDRX annual EBITDA has changed by -$4.32M (-2.65%)
What is GoodRx Holdings, Inc. quarterly EBITDA?
The current quarterly EBITDA of GDRX is $50.03M
What is the all time high quarterly EBITDA for GoodRx Holdings, Inc.?
GoodRx Holdings, Inc. all-time high quarterly EBITDA is $50.03M
What is GoodRx Holdings, Inc. quarterly EBITDA year-on-year change?
Over the past year, GDRX quarterly EBITDA has changed by +$6.86M (+15.88%)
What is GoodRx Holdings, Inc. TTM EBITDA?
The current TTM EBITDA of GDRX is $178.12M
What is the all time high TTM EBITDA for GoodRx Holdings, Inc.?
GoodRx Holdings, Inc. all-time high TTM EBITDA is $178.12M
What is GoodRx Holdings, Inc. TTM EBITDA year-on-year change?
Over the past year, GDRX TTM EBITDA has changed by +$69.13M (+63.43%)